Céline Gélinas, PhD

Dr. Gélinas is Senior Associate Dean for Research at the Robert Wood Johnson Medical School (RWJMS) (since 2013) and Chair of the Biochemistry and Molecular Biology Department (since 2018).  She is co-leader of the Regulatory Core of the NIH CTSA-sponsored New Jersey Alliance for Clinical and Translational Science (NJ ACTS), and co-lead of the NIH-funded Clinician Research Experiential Summer Training (CREST) Program for medical and pharmacy students.  She previously was the Associate Dean for Research and institutional official at RWJMS from 2008-2013.

Dr. Gélinas received her B.S degree in Chemistry/Biochemistry and a Ph.D. in Microbiology from the Université de Sherbrooke (Canada).  She was recruited to RWJMS, following post-doctoral training with Nobel Laureate Dr. Howard M. Temin at the McArdle Laboratory for Cancer Research at the University of Wisconsin-Madison.  Her basic and translational research has focused on the NF-kappa B signaling pathway and its roles in gene regulation and cancer, and more recently in the cellular response to viruses and viral latency reactivation.  Her work has provided important insights into mechanisms of disease ranging from cancer, metastasis and chemoresistance to viral reactivation, and has identified potential therapeutic targets.  Her research has been funded by the NIH, the Department of Defense CDMRP, the New Jersey Commission on Cancer Research and multiple foundations.  She served on several NIH study sections and published nearly 60 peer-reviewed articles, book chapters and invited reviews.  She was selected as National Cancer Institute of Canada King George V Silver Jubilee Postdoctoral Fellow, was named Master Educator in 2006 and was elected Fellow of the American Academy of Microbiology in 2010.